BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies

A Alu, H Lei, X Han, Y Wei, X Wei - Journal of Hematology & Oncology, 2022 - Springer
Bruton's tyrosine kinase (BTK) is an essential component of multiple signaling pathways that
regulate B cell and myeloid cell proliferation, survival, and functions, making it a promising …

Role of Bruton's tyrosine kinase in B cells and malignancies

S Pal Singh, F Dammeijer, RW Hendriks - Molecular cancer, 2018 - Springer
Bruton's tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic
signaling that is critical for proliferation and survival of leukemic cells in many B cell …

Targeting B cell receptor signalling in cancer: preclinical and clinical advances

JA Burger, A Wiestner - Nature Reviews Cancer, 2018 - nature.com
B cell receptor (BCR) signalling is crucial for normal B cell development and adaptive
immunity. BCR signalling also supports the survival and growth of malignant B cells in …

Chronic lymphocytic leukaemia: from genetics to treatment

F Bosch, R Dalla-Favera - Nature reviews Clinical oncology, 2019 - nature.com
Chronic lymphocytic leukaemia (CLL), the most frequent type of leukaemia in adults, is a
lymphoproliferative disorder that is characterized by the expansion of monoclonal, mature …

Treatment of chronic lymphocytic leukemia

JA Burger - New England Journal of Medicine, 2020 - Mass Medical Soc
Chronic Lymphocytic Leukemia Treatment of CLL, the most common leukemia in the West,
has undergone a revolution in the past few years with the development of agents that target …

Targeting Bruton's tyrosine kinase in B cell malignancies

RW Hendriks, S Yuvaraj, LP Kil - Nature Reviews Cancer, 2014 - nature.com
Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and
functions as an important regulator of cell proliferation and cell survival in various B cell …

The molecular pathogenesis of chronic lymphocytic leukaemia

G Fabbri, R Dalla-Favera - Nature Reviews Cancer, 2016 - nature.com
Recent investigations have provided an increasingly complete picture of the genetic
landscape of chronic lymphocytic leukaemia (CLL). These analyses revealed that the CLL …

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

A Agathangelidis, A Chatzidimitriou… - Blood, The Journal …, 2021 - ashpublications.org
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients
with (quasi) identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

JC Riches, JK Davies, F McClanahan… - Blood, The Journal …, 2013 - ashpublications.org
T-cell exhaustion, originally described in chronic viral infections, was recently reported in
solid and hematologic cancers. It is not defined whether exhaustion contributes to T-cell …

[HTML][HTML] Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies

J Delgado, F Nadeu, D Colomer, E Campo - Haematologica, 2020 - ncbi.nlm.nih.gov
Chronic lymphocytic leukemia is a well-defined lymphoid neoplasm with very
heterogeneous biological and clinical behavior. The last decade has been remarkably …